O'Shaughnessy Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $432K | Buy |
19,895
+1,046
| +6% | +$22.7K | ﹤0.01% | 1458 |
|
|
2025
Q1 | $457K | Sell |
18,849
-500
| -3% | -$12.1K | ﹤0.01% | 1366 |
|
|
2024
Q4 | $404K | Buy |
19,349
+8,367
| +76% | +$175K | ﹤0.01% | 1374 |
|
|
2024
Q3 | $227K | Buy |
+10,982
| New | +$227K | ﹤0.01% | 1618 |
|
|
2023
Q2 | – | Sell |
-11,447
| Closed | -$190K | – | 1516 |
|
|
2023
Q1 | $190K | Buy |
11,447
+1,388
| +14% | +$23K | ﹤0.01% | 1213 |
|
|
2022
Q4 | $187K | Buy |
+10,059
| New | +$187K | ﹤0.01% | 1127 |
|
|
2022
Q1 | – | Sell |
-73,599
| Closed | -$498K | – | 1291 |
|
|
2021
Q4 | $498K | Sell |
73,599
-4,819
| -6% | -$32.6K | 0.01% | 693 |
|
|
2021
Q3 | $416K | Sell |
78,418
-24,624
| -24% | -$131K | 0.01% | 724 |
|
|
2021
Q2 | $592K | Buy |
103,042
+11,414
| +12% | +$65.6K | 0.01% | 600 |
|
|
2021
Q1 | $422K | Buy |
91,628
+78,553
| +601% | +$362K | 0.01% | 673 |
|
|
2020
Q4 | $44K | Buy |
+13,075
| New | +$44K | ﹤0.01% | 1269 |
|